LENZ THERAPEUTICS, INC. Increase (Decrease) in Inventories
LENZ THERAPEUTICS, INC. (LENZ) reported Increase (Decrease) in Inventories of $870.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-11
- LENZ THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$19.00K.
- LENZ THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $889.00K.
- LENZ THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $3.33M.
- LENZ THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $949.00K.
- LENZ THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2025 was $4.28M.
- LENZ THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2024 was $0.00.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $870.00K 10-Q · filed 2026-08-11 | $4.20M derived: sum of 3 quarters · filed 2026-08-11 | $5.14M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $889.00K 10-Q · filed 2026-05-11 | $4.21M derived: sum of 2 quarters · filed 2026-05-11 | $5.16M derived: sum of 3 quarters · filed 2026-05-11 | $5.16M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $4.28M derived: sum of 2 quarters · filed 2026-03-24 | $4.28M derived: sum of 3 quarters · filed 2026-08-11 | $4.28M 10-K · filed 2026-03-24 |
| 2025-09-30 | $949.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $949.00K derived: sum of 2 quarters · filed 2026-08-11 | $949.00K 10-Q · filed 2025-11-05 | $949.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 10-K · filed 2026-03-24 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |